WAINZUA 45 mg, solution for injection in a pre-filled pen syringe, 0.8 ml
Active ingredients: ÉPLONTERSEN, ÉPLONTERSEN SODIQUE
Commercialized according to BDPMDispensing in France: Prescription only
Solution for injectionsyringe, 0.8 mlsous-cutanée
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- WAINZUA 45 mg, solution injectable en stylo prérempli
- Pharmaceutical form
- solution injectable
- Route of administration
- sous-cutanée
- Presentation description
- 1 seringue préremplie en verre de 0,8 mL dans un stylo prérempli
- Marketing authorisation holder
- ASTRAZENECA AB
- Reimbursement according to BDPM
- 30 %
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 7 Sept 2026
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Prescribed by a hospital doctor
- Prescribed by specialists only
- Enhanced ANSM monitoring
- Yes
BDPM identifiers
CIS
65079351CIP73030653CIP133400930306536Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| ÉPLONTERSEN SODIQUEsolution | — | SA |
| ÉPLONTERSENsolution | 45 mg · une seringue préremplie de 0,8 mL | FT |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.